Reshape Biotech, a Danish company, has raised $8.1 million in seed funding, the largest in Denmark’s history. The company provides an affordable solution for lab automation using advanced technology in the food and biotech industries. The platform offers a new R&D infrastructure that enables digitized research to be shared globally, resulting in studies being conducted 1000X more rapidly. With 10X growth in revenue and 110 robotic systems, Reshape is revolutionizing the way microbiology experiments are shown. The company plans to open a location in North America and expand its robotic fleet, with the vision of making discovery more accessible and affordable for biotech. With a distribution network in Europe and the US, Reshape Biotech is dedicated to digitizing research and enabling collaboration globally.
Reshape Biotech, a Danish integrated hardware and software platform digitizing microbiology experiments, has announced an investment of $8.1 million, the most significant seed round in Denmark’s history. The funding was led by ACME Capital and supported by FundersClub, Y Combinator, Unity co-founder Nicholas Francis, and Per Falholt.
Reshape Biotech provides an affordable solution for lab automation in the food and biotech industries by using advanced technology such as mechatronics, cloud computing, machine-learning-based data analysis, and a deep understanding of biotech applications. The company’s robots are vertically integrated, capturing data accurately and eliminating redundant processes, making it easy for customers to digitize microbiology experiments and collaborate globally. Reshape currently serves 20 customers in various fields, such as agricultural and food microbiology, ingredients development, and industrial biotech, and has seen 100% customer retention and 300% YoY growth.
The Reshape platform offers a new R&D infrastructure that enables digitized research to be shared globally, resulting in research that can be conducted 1000X more rapidly than traditional methods. With a growth of 10X in revenue and 110 robotic systems, Reshape is revolutionizing the way microbiology experiments are conducted and has the potential to change the integrity of food supplies, biotech, and more.
Soon, Reshape plans to open a location in North America and expand its robotic fleet by 100X, along with development, application science, and sales efforts. The company’s vision is to make the discovery process more accessible and affordable for biotech, considered the most important industry of the 21st century.
With its headquarters in Copenhagen and a distribution network in Europe and the US, Reshape Biotech is dedicated to digitizing research and enabling collaboration globally through a new generation of lab equipment and infrastructure. The company’s technology has the potential to lead to healthier societies and a better planet by digitizing the laborious processes in R&D for the food and biotech industries.
Image provided by Reshape Biotech
2 Comments